Urotensin-II receptor: a double identity receptor involved in vasoconstriction and in the development of digestive tract cancers and other tumors.

In conclusion, a new weapon in the treatment of human cancers is highlighting a new scenario for the future.
PMID: 27338741 [PubMed - as supplied by publisher]

Source: Current Cancer Drug Targets - June 19, 2016 Category: Cancer & Oncology Authors: Federico A, Zappavigna S, Dallio M, Misso G, Merlino F, Loguercio C, Novellino E, Paolo Grieco PX, Caraglia M Tags: Curr Cancer Drug Targets Source Type: research